Connect your AI

LivaNova LIVN Total Current Liabilities

Total Current Liabilities at other companies

AbbottABT

$18.38B+41.3%

HaemoneticsHAE

$282.6M-51.1%

MedtronicMDT

$11.66B-9.5%

ResMedRMD

$1.35B+43.7%

Boston ScientificBSX

$4.57B-9.6%

StrykerSYK

$6.32B-20.4%

Other financials

Income statement

Revenue$362.3M+14.3%

Gross profit$243.7M+12.7%

Operating income$41.5M-14.7%

Net income$22.3M+107%

EPS (diluted)$0.40+107%

Balance sheet

Cash & equivalents$539.7M-26.9%

Total debt$340.9M-49.7%

Total equity$1.2B+17.1%

Total assets$2.5B-1.7%

Cash flow

Operating cash flow$15.2M-36.5%

CapEx$14.3M+32.4%

Free cash flow$926.0K-93.0%

Valuation

Market cap$4.31B+62.8%

Enterprise value$4.11B+58.0%

P/S3×+0.9×

Profitability

Gross margin67.5%-0.5pp

Operating margin13.4%+0.8pp

Net margin-16.1%-18.0pp

FCF margin11.2%-0.2pp

Returns & leverage

Return on equity-17.6%-19.5pp

Debt / equity0.3×-0.4×

Current ratio1.3×-0.2×

Where this comes from

Reported directly by LivaNova in its filing.

Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.

The official record: LivaNova’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about LivaNova's total current liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is LivaNova's total current liabilities?: LivaNova (LIVN) reported total current liabilities of $762.48M in Q1 2026.
How has LivaNova's total current liabilities changed year-over-year?: LivaNova's total current liabilities increased by 2.8% year-over-year, from $741.57M to $762.48M.
What is the long-term trend for LivaNova's total current liabilities?: Over 5 years (2020 to 2025), LivaNova's total current liabilities has grown at a 21.2% compound annual growth rate (CAGR), from $309.05M to $808.07M.
What does total current liabilities mean?: The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.